Hepatitis C Trial, RecruitingNCT05248555Sponsor: Kirby InstituteCondition: Hepatitis C
Printed from Voxsanity (voxsanity.com.au) — NCT05248555 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
AI generated eligibility summary.
Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source.
How we use AI
Who might be able to join this trial:
People who are 18 years of age or older.
People who have received a hepatitis C (HCV) test at a point-of-care testing site (meaning a test done on-site rather than sent to a laboratory).
Who may not be able to join:
There are no listed exclusion criteria for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Justice Health and Forensic Mental Health Network, Sydney, New South Wales
Lotus Glen Correctional Centre, Cairns, Queensland
Hepatitis Queensland, Coorparoo, Queensland
West Moreton Hospital and Health Service, Ipswich, Queensland
Townsville Correctional Centre, Townsville, Queensland
Woodford Correctional Centre, Woodford, Queensland
South Australian Prison Health Service, Marden, South Australia
Mount Gambier Priosn, Mount Gambier, South Australia
St Vincent's Correctional Health Services, Fitzroy, Victoria
Medically Supervised Injecting Room, Melbourne, Victoria
Geo Healthcare - The Geo Group Australia Pty Ltd, Ravenhall, Victoria
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Voxsanity
Clinical trials and treatments, explained plainly · voxsanity.com.au
Date:
To: My Doctor
Re: Clinical trial enquiry
I am writing to enquire about the following clinical trial which may be relevant to my care:
Trial: NCT05248555
Sponsor: Kirby Institute
Phase: Not Applicable
Status: Recruiting
Condition: Hepatitis C
Trial contact: +61293850900
More information: https://clinicaltrials.gov/study/NCT05248555
Eligibility summary (AI generated)
Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.
Who might be able to join this trial:
People who are 18 years of age or older.
People who have received a hepatitis C (HCV) test at a point-of-care testing site (meaning a test done on-site rather than sent to a laboratory).
Who may not be able to join:
There are no listed exclusion criteria for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.
This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Kirby Institute
Registry
ClinicalTrials.gov
Start date
1 December 2021
Est. completion
1 December 2024
Where this trial is recruiting
🇦🇺 Australia
11 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
The proportion of HCV infected participants who initiate HCV treatment at 12 weeks
Can't join this trial?
Expanded access pathways
If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.